Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 238

1.

Physical risk factors of hemorrhagic complications associated with Angio-Seal closure device use in neurointerventional procedures.

Aida Y, Misaki K, Kamide T, Mohri M, Uchiyama N, Nakada M.

World Neurosurg. 2018 Jan 8. pii: S1878-8750(18)30034-2. doi: 10.1016/j.wneu.2017.12.179. [Epub ahead of print]

PMID:
29325953
2.

[EXPRESS] Extracellular N-acetylaspartylglutamate released in the nucleus accumbens modulates the pain sensation: analysis using a microdialysis/mass spectrometry integrated system.

Watanabe M, Sugiura Y, Sugiyama E, Narita M, Navratilova E, Kondo T, Uchiyama N, Yamanaka A, Kuzumaki N, Porreca F, Narita M.

Mol Pain. 2018 Jan 1:1744806918754934. doi: 10.1177/1744806918754934. [Epub ahead of print] No abstract available.

PMID:
29310499
3.

[Factors for Degaussing of a Cochlear Implant Magnet in the MR Scanner].

Koganezawa T, Uchiyama N, Teshigawara M, Ogura A.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73(12):1216-1223. doi: 10.6009/jjrt.2017_JSRT_73.12.1216. Japanese.

4.

Discovery of a Novel Series of Pyrazolo[1,5-a]pyrimidine-Based Phosphodiesterase 2A Inhibitors Structurally Different from N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), for the Treatment of Cognitive Disorders.

Mikami S, Kawasaki M, Ikeda S, Negoro N, Nakamura S, Nomura I, Ashizawa T, Kokubo H, Hoffman ID, Zou H, Oki H, Uchiyama N, Hiura Y, Miyamoto M, Itou Y, Nakashima M, Iwashita H, Taniguchi T.

Chem Pharm Bull (Tokyo). 2017;65(11):1058-1077. doi: 10.1248/cpb.c17-00564.

5.

Survey on the Original Plant Species of Crude Drugs Distributed as Cynanchi Wilfordii Radix and Its Related Crude Drugs in the Korean and Chinese Markets.

Sato-Masumoto N, Uchikura T, Sugiwaki H, Yoshimura M, Masada S, Atsumi T, Watanabe M, Tanaka N, Uchiyama N, Amakura Y, Hakamatsuka T.

Biol Pharm Bull. 2017;40(10):1693-1699. doi: 10.1248/bpb.b17-00226.

6.

Natural (∆9-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB1 receptor.

Malyshevskaya O, Aritake K, Kaushik MK, Uchiyama N, Cherasse Y, Kikura-Hanajiri R, Urade Y.

Sci Rep. 2017 Sep 5;7(1):10516. doi: 10.1038/s41598-017-10447-2.

7.

The Optimal Pad Material for Fat Suppression of Breast MRI.

Teshigawara M, Ogura A, Uchiyama N, Koganezawa T.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73(8):664-671. doi: 10.6009/jjrt.2017_JSRT_73.8.664. Japanese.

8.

Discovery of Clinical Candidate N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915): A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders.

Mikami S, Nakamura S, Ashizawa T, Nomura I, Kawasaki M, Sasaki S, Oki H, Kokubo H, Hoffman ID, Zou H, Uchiyama N, Nakashima K, Kamiguchi N, Imada H, Suzuki N, Iwashita H, Taniguchi T.

J Med Chem. 2017 Sep 28;60(18):7677-7702. doi: 10.1021/acs.jmedchem.7b00807. Epub 2017 Sep 5.

PMID:
28796496
9.

Two flavone C-glycosides as quality control markers for the manufacturing process of ephedrine alkaloids-free Ephedra Herb extract (EFE) as a crude drug preparation.

Oshima N, Maruyama T, Yamashita T, Uchiyama N, Amakura Y, Hyuga S, Hyuga M, Nakamori S, Takemoto H, Kobayashi Y, Hakamatsuka T, Odaguchi H, Hanawa T, Goda Y.

J Nat Med. 2017 Aug 3. doi: 10.1007/s11418-017-1111-8. [Epub ahead of print]

PMID:
28776291
10.

Chemical Analysis of Counterfeit Hepatitis C Drug Found in Japan.

Uchiyama N, Kamakura H, Masada S, Tsujimoto T, Hosoe J, Tokumoto H, Maruyama T, Goda Y, Hakamatsuka T.

Yakugaku Zasshi. 2017 Oct 1;137(10):1265-1276. doi: 10.1248/yakushi.17-00136. Epub 2017 Jul 19. Japanese.

11.

Aristeromycin and DZNeP cause growth inhibition of prostate cancer via induction of mir-26a.

Uchiyama N, Tanaka Y, Kawamoto T.

Eur J Pharmacol. 2017 Oct 5;812:138-146. doi: 10.1016/j.ejphar.2017.07.023. Epub 2017 Jul 10.

PMID:
28705714
12.

Fabry disease.

Yuasa T, Takenaka T, Higuchi K, Uchiyama N, Horizoe Y, Cyaen H, Mizukami N, Takasaki K, Kisanuki A, Miyata M, Ohishi M.

J Echocardiogr. 2017 Dec;15(4):151-157. doi: 10.1007/s12574-017-0340-x. Epub 2017 Jul 3.

PMID:
28674962
13.

2-Aminomethylthieno[3,2-d]pyrimidin-4(3H)-ones bearing 3-methylpyrazole hinge binding moiety: Highly potent, selective, and time-dependent inhibitors of Cdc7 kinase.

Kurasawa O, Homma M, Oguro Y, Miyazaki T, Mori K, Uchiyama N, Iwai K, Ohashi A, Hara H, Yoshida S, Cho N.

Bioorg Med Chem. 2017 Jul 15;25(14):3658-3670. doi: 10.1016/j.bmc.2017.04.044. Epub 2017 May 2.

PMID:
28533114
14.

Identification of AHCY inhibitors using novel high-throughput mass spectrometry.

Uchiyama N, Dougan DR, Lawson JD, Kimura H, Matsumoto SI, Tanaka Y, Kawamoto T.

Biochem Biophys Res Commun. 2017 Sep 9;491(1):1-7. doi: 10.1016/j.bbrc.2017.05.107. Epub 2017 May 19.

PMID:
28533090
15.

Anomalies of the Middle Cerebral Artery.

Uchiyama N.

Neurol Med Chir (Tokyo). 2017 Jun 15;57(6):261-266. doi: 10.2176/nmc.ra.2017-0043. Epub 2017 Apr 27.

16.

Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.

Furuta T, Sabit H, Dong Y, Miyashita K, Kinoshita M, Uchiyama N, Hayashi Y, Hayashi Y, Minamoto T, Nakada M.

Oncotarget. 2017 Apr 4;8(14):22811-22824. doi: 10.18632/oncotarget.15206.

17.

A Pediatric Case of Reversible Cerebral Vasoconstriction Syndrome With Similar Radiographic Findings to Posterior Reversible Encephalopathy Syndrome.

Kamide T, Tsutsui T, Misaki K, Sano H, Mohri M, Uchiyama N, Nakada M.

Pediatr Neurol. 2017 Jun;71:73-76. doi: 10.1016/j.pediatrneurol.2017.02.008. Epub 2017 Feb 20.

PMID:
28372869
19.

Inflow hemodynamics evaluated by using four-dimensional flow magnetic resonance imaging and the size ratio of unruptured cerebral aneurysms.

Futami K, Nambu I, Kitabayashi T, Sano H, Misaki K, Uchiyama N, Nakada M.

Neuroradiology. 2017 Apr;59(4):411-418. doi: 10.1007/s00234-017-1801-7. Epub 2017 Mar 7.

PMID:
28271159
20.

Long-term predictive factors of the morphology based outcome in bare platinum coiled intracranial aneurysms: Evaluation by pre- and post-contrast 3D time-of-flight MR angiography.

Ueda F, Uchiyama N, Mohri M, Misaki K, Matsui O, Kida S, Sanada J, Yoshikawa J, Aburano H, Yoshie Y, Gabata T.

Neurol Neurochir Pol. 2017 Mar - Apr;51(2):116-126. doi: 10.1016/j.pjnns.2017.01.002. Epub 2017 Jan 21.

PMID:
28256206

Supplemental Content

Loading ...
Support Center